[go: up one dir, main page]

DK2897594T3 - Farmaceutisk sammensætning - Google Patents

Farmaceutisk sammensætning Download PDF

Info

Publication number
DK2897594T3
DK2897594T3 DK13771084.4T DK13771084T DK2897594T3 DK 2897594 T3 DK2897594 T3 DK 2897594T3 DK 13771084 T DK13771084 T DK 13771084T DK 2897594 T3 DK2897594 T3 DK 2897594T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK13771084.4T
Other languages
English (en)
Inventor
Soren Halskov
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK2897594T3 publication Critical patent/DK2897594T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK13771084.4T 2012-09-21 2013-09-20 Farmaceutisk sammensætning DK2897594T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12185339 2012-09-21
EP13160799 2013-03-25
PCT/EP2013/069570 WO2014044794A2 (en) 2012-09-21 2013-09-20 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK2897594T3 true DK2897594T3 (da) 2020-06-29

Family

ID=49293599

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13771084.4T DK2897594T3 (da) 2012-09-21 2013-09-20 Farmaceutisk sammensætning

Country Status (8)

Country Link
US (3) US10449158B2 (da)
EP (1) EP2897594B1 (da)
JP (1) JP6456830B2 (da)
CN (2) CN111053759A (da)
CA (1) CA2885278A1 (da)
DK (1) DK2897594T3 (da)
ES (1) ES2801801T3 (da)
WO (1) WO2014044794A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2897594T3 (da) * 2012-09-21 2020-06-29 Ferring Bv Farmaceutisk sammensætning
EP2978413A1 (en) 2013-03-25 2016-02-03 Ferring BV Composition for the treatment of disease
CN105362496A (zh) * 2015-06-13 2016-03-02 国网山东省电力公司临沂供电公司 一种用于治疗电力职工电光性眼炎的防护品
KR20180070591A (ko) * 2015-10-26 2018-06-26 다이이찌 산쿄 가부시키가이샤 다공질 재료의 대장 또는 소장 하부에 대한 딜리버리 제제
WO2018063216A1 (en) * 2016-09-29 2018-04-05 M Pharmaceutical Usa Inc. Dual compartment capsule for the administration of orlistat
GB2569119A (en) * 2017-12-05 2019-06-12 Rainbow Valley Nutrients Ltd An aqueous beverage containing microencapsulated food supplement
MX2021001394A (es) 2018-08-05 2021-04-12 Da Volterra Metodo para mejorar la eficacia de un agente anticanceroso.
US20210290741A1 (en) 2018-08-05 2021-09-23 Da Volterra Compositions for the treatment of graft versus host disease
EP3610860A1 (en) * 2018-08-15 2020-02-19 Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Composition of carbon dioxide absorbent or adsorbent, whereby the said composition contains a polymeric coating selected from silicone rubber and cellulose
DE102021127957A1 (de) 2021-10-27 2023-04-27 Rheinisch-Westfälische Technische Hochschule Aachen, Körperschaft des öffentlichen Rechts Umhüllte Wirkstoffformulierung zu kontrollierten in vivo-Aufnahme von CO2
EP4422595A1 (de) 2021-10-27 2024-09-04 O11-biomedical GmbH Umhüllte wirkstoffformulierung zu kontrollierten in vivo-aufnahme von co2

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5489010A (en) * 1977-12-27 1979-07-14 Kureha Chem Ind Co Ltd Spherical activated charcoal antidote
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
WO1998022096A1 (en) * 1996-11-15 1998-05-28 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US6706263B2 (en) * 1999-04-30 2004-03-16 Kibow Biotech Inc. Composition for alleviating symptoms of uremia in patients
US20040166248A1 (en) * 2000-12-15 2004-08-26 Sheng-Hsin Hu Coated activated carbon
US7163696B2 (en) * 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
US8048413B2 (en) * 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
US8110186B2 (en) * 2006-09-18 2012-02-07 Chelatexx, LLC Method to maintain the efficacy of orlistat
WO2008048469A2 (en) * 2006-10-13 2008-04-24 Actavis Group Pct Hf Controlled-release coated dosage forms containing galantamine
WO2009049239A1 (en) 2007-10-12 2009-04-16 Ocera Therapeutics, Inc. Use of adsorbent carbon microspheres to treat pouchitis
EP2538930B1 (en) 2010-02-23 2016-06-15 Da Volterra Formulations for oral delivery of adsorbents in the gut
TWI643623B (zh) 2011-10-03 2018-12-11 菲瑞茵公司 用於瘻管之治療的組成物
DK2897594T3 (da) * 2012-09-21 2020-06-29 Ferring Bv Farmaceutisk sammensætning
EP2978413A1 (en) 2013-03-25 2016-02-03 Ferring BV Composition for the treatment of disease

Also Published As

Publication number Publication date
EP2897594A2 (en) 2015-07-29
US10449158B2 (en) 2019-10-22
JP2015529233A (ja) 2015-10-05
CN104797243A (zh) 2015-07-22
US20210196647A1 (en) 2021-07-01
US20150245999A1 (en) 2015-09-03
CN111053759A (zh) 2020-04-24
WO2014044794A3 (en) 2014-06-19
JP6456830B2 (ja) 2019-01-23
ES2801801T3 (es) 2021-01-13
CA2885278A1 (en) 2014-03-27
US11712422B2 (en) 2023-08-01
US20240016753A1 (en) 2024-01-18
WO2014044794A2 (en) 2014-03-27
EP2897594B1 (en) 2020-04-08

Similar Documents

Publication Publication Date Title
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
SMT201700008B (it) Composizione farmaceutica
DK2694038T3 (da) Farmaceutisk sammensætning
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
SI3725778T1 (sl) Formulacije enzalutamida
BR112014003052A2 (pt) composições farmacêuticas
BR112015002738A2 (pt) composto , e , composição farmacêutica
FR2997014B1 (fr) Composition sterile dermo-injectable
DK2939692T3 (da) Nasal influenzavaccinesammensætning
BR112014032798A2 (pt) composição
DK3246018T3 (da) Farmaceutisk sammensætning
CO6930367A2 (es) Composiciones farmaceúticas
ZA201501930B (en) Pharmaceutical composition
EP2934454C0 (en) ANTI-DANDRUFF COMPOSITION
EE201300005A (et) Ravimkoostis
ME03413B (me) Kompozicije које sadrže peg i askorbat
DK2897594T3 (da) Farmaceutisk sammensætning
HUE040370T2 (hu) Gyógyszerkészítmények
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
DK2815752T3 (da) Oral farmaceutisk sammensætning
CL2014003283A1 (es) Formulación farmacéutica.
EP2920370A4 (en) POST
EP2769718A4 (en) MEDICAL COMPOSITION
EP2883547A4 (en) MEDICINE
HK1204947A1 (zh) 滅菌組合物